🇺🇸 FDA

Intelligence Platform

Patents

Browse 373 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7423118

IAPS associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420045

IAPs associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413870

SAK: modulation of cellular proliferation for treatment of cancer

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or riba

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378251

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368257

Modulators of lymphocyte activation, Mkk3b compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358259

HCV inhibitors and methods of using them

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332602

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332484

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329672

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329671

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326790

Diphenylisoxazole compounds and hydro isomers thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285383

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244576

Modulators of angiogenesis

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7241581

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7220745

Heterocyclic compounds useful to treat HCV

Rigel Pharmaceuticals, Inc. · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208289

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157473

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7153880

Substituted diphenyl heterocycles useful for treating HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141434

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122542

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060827

Intermediates useful for making 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7045284

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6979549

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired